Lucius Annaeus Seneca. Moral Letters to Lucilius. Toronto: Aegitas; 2015.
2.
OlinJWWhiteCJArmstrongEJ, et al.Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options. J Am Coll Cardiol2016; 67: 1338–1357.
3.
CampiaUGerhard-HermanMPiazzaG, et al.Peripheral Artery Disease: Past, Present, and Future. Am J Med2019. epub ahead of print, May 29. DOI: S0002-9343(19)30435–8.
4.
Biondi-ZoccaiGGAbbateALiuzzoG, et al.Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol2003; 41: 1071–1077.
5.
Biondi-ZoccaiG. Why interventional cardiologists may be the most suitable specialists for the endovascular management of peripheral artery disease. Minerva Cardioangiol2013; 61: 367–370.
6.
Biondi-ZoccaiGGSangiorgiG. Below-the-knee/ankle revascularization: tools of the trade. J Endovasc Ther2009; 16: 613–616.
7.
Guirguis-Blake JM, Evans CV, Redmond N, et al. Screening for peripheral artery disease using the Ankle-Brachial Index: An updated systematic review for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality (US), 2018.
8.
KhanNARahimSAAnandSS, et al.Does the clinical examination predict lower extremity peripheral arterial disease?JAMA2006 Feb 1; 295: 536–546.
9.
BendermacherBLTeijinkJAWilligendaelEM, et al.A clinical prediction model for the presence of peripheral arterial disease–the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study. Vasc Med2007; 12: 5–11.
10.
CournotMBoccalonHCambouJP, et al.Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects. J Vasc Surg2007; 46: 1215–1221.
11.
MakdisseMRamosLRMoreiraF, et al.A risk score for predicting peripheral arterial disease in individuals 75 years or older. Arq Bras Cardiol2007; 88: 630–636.
12.
DaskalopoulouSSPathmarajahMKakkosSK, et al.Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J2008; 72: 441–418.
13.
SuominenVRantanenTVenermoM, et al.Prevalence and risk factors of PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg2008; 35: 709–714.
14.
ZhangYHuangJWangP. A Prediction Model for the Peripheral Arterial Disease Using NHANES Data. Medicine (Baltimore)2016; 95: e3454–e3454.
15.
Tunstall-PedoeHPetersSAEWoodwardM, et al.Twenty-Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC). J Am Heart Assoc2017; 6: e005967–e005967.
16.
MastrangeliSCarnevaleRCavarrettaE, et al.Predictors of oxidative stress and vascular function in an experimental study of tobacco versus electronic cigarettes: A post hoc analysis of the SUR-VAPES 1 Study. Tob Induc Dis2018; 16: 18–18.
17.
Biondi-ZoccaiGSciarrettaSBullenC, et al.Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: The Sapienza University of Rome-Vascular assessment of proatherosclerotic effects of smoking (SUR - VAPES) 2 randomized trial. J Am Heart Assoc2019; 8: e010455–e010455.
18.
Rosas-PeraltaMJiménez-GenchiGM. New Challenges for Hypertension Treatment. Arch Med Res2018; 49: 548–557.
19.
LuYBallewSHTanakaH, et al.2017 AHA/ACC blood pressure classification and incident peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Prev Cardiol. 2020; 27: 51–59.
20.
WheltonPKCareyRMAronowWS, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2018; 71: e127–e248.
